Colgate-Palmolive Co. (CL) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts CL Hot Sheet
Join SI Premium – FREE
Colgate-Palmolive Co. (NYSE: CL) reported Q3 EPS of $1.31, $0.01 better than the analyst estimate of $1.30. Revenue for the quarter came in at $4.38 billion versus the consensus estimate of $4.38 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein SocGen on Colgate-Palmolive Company (CL): 'Will International continue to sustain company growth?'
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
